Abstract

FDA Considers Sertindole, a SecondGeneration Antipsychotic

Author(s): Peter F. Buckley

Sertindole, an antipsychotic that was previously reviewed by the United States Food and Drug Administration (FDA) in the late 1990s, has recently been submitted as a new drug application for consideration for approval as a treatment for schizophrenia

• PDF